Omega Healthcare Investors (OHI) Set to Announce Quarterly Earnings on Wednesday

Omega Healthcare Investors (NYSE:OHI) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.69 per share for the quarter. Omega Healthcare Investors has set its FY24 guidance at $2.78-$2.84 EPS and its FY 2024 guidance at 2.780-2.840 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a net margin of 33.52% and a return on equity of 8.61%. The company had revenue of $252.70 million during the quarter, compared to analyst estimates of $205.92 million. During the same period in the previous year, the firm posted $0.74 earnings per share. The company’s revenue was up 17.5% compared to the same quarter last year. On average, analysts expect Omega Healthcare Investors to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Omega Healthcare Investors Trading Down 0.2 %

Shares of NYSE:OHI opened at $41.24 on Wednesday. The company has a current ratio of 5.79, a quick ratio of 5.79 and a debt-to-equity ratio of 1.19. The company has a market capitalization of $10.63 billion, a PE ratio of 31.48, a PEG ratio of 1.34 and a beta of 1.00. The business has a 50 day moving average of $39.86 and a two-hundred day moving average of $35.42. Omega Healthcare Investors has a 12-month low of $27.53 and a 12-month high of $41.73.

Analysts Set New Price Targets

OHI has been the subject of several analyst reports. Scotiabank upped their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a report on Monday, August 26th. Berenberg Bank began coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They issued a “buy” rating and a $45.00 price target on the stock. Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 price objective (up previously from $40.00) on shares of Omega Healthcare Investors in a report on Tuesday, October 1st. Truist Financial raised their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a research note on Wednesday, September 4th. Finally, BMO Capital Markets raised their price target on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a “market perform” rating in a research note on Monday, October 7th. Eight analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, Omega Healthcare Investors presently has an average rating of “Hold” and an average target price of $37.80.

Insider Buying and Selling at Omega Healthcare Investors

In related news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the transaction, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares of the company’s stock, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the transaction, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is currently owned by insiders.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.